谷歌浏览器插件
订阅小程序
在清言上使用

Successful Correction by Prime Editing of a Mutation in the RYR1 Gene Responsible for a Myopathy

Cells(2023)

引用 0|浏览9
暂无评分
摘要
We report the first correction from prime editing a mutation in the RYR1 gene, paving the way to gene therapies for RYR1-related myopathies. The RYR1 gene codes for a calcium channel named Ryanodine receptor 1, which is expressed in skeletal muscle fibers. The failure of this channel causes muscle weakness in patients, which leads to motor disabilities. Currently, there are no effective treatments for these diseases, which are mainly caused by point mutations. Prime editing allows for the modification of precise nucleotides in the DNA. Our results showed a 59% correction rate of the T4709M mutation in the RYR1 gene in human myoblasts by RNA delivery of the prime editing components. It is to be noted that T4709M is recessive and, thus, persons having a heterozygous mutation are healthy. These results are the first demonstration that correcting mutations in the RYR1 gene is possible.
更多
查看译文
关键词
prime editing,CRISPR/Cas9,gene editing,gene therapy,RYR1-related diseases,neuromuscular diseases,RYR1 gene,mutations
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要